Science ❯ Medical Research ❯ Oncology
Monoclonal Antibodies Personalized Medicine
Backed by more than £1 million in memorial fundraising, the Win-Glio study will recruit 16 glioblastoma patients over 18 months to receive ipilimumab before conventional therapy.